Beyfortus

Beyfortus (Nirsevimab) is a respiratory syncytial virus (RSV) preventive medication administered intramuscularly. It is designed to protect infants and young children from RSV infections, a common cause of respiratory illness.

Beyfortus is primarily used for the prevention of RSV infections in infants and young children. RSV is a common virus that can cause severe respiratory illness, particularly in young children. This medication is administered intramuscularly and is intended to provide protection against RSV during the season when the virus is most prevalent.

Beyfortus may cause local reactions at the injection site, such as redness, swelling, or pain. Some individuals might experience systemic effects like fever, irritability, or decreased appetite. These effects are generally mild and temporary.

Beyfortus should be administered by healthcare professionals. It is important to inform your healthcare provider about any allergies or medical conditions before receiving this medication. Always follow the storage and handling instructions provided with the product.

There is limited information available on the interactions of Beyfortus with other medications. However, it is always advisable to inform your healthcare provider about all the medications you are currently taking to avoid potential interactions.